The Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA) has updated the Vaccination Guidelines it offers to veterinary surgeons.
The association says its Canine and Feline Vaccination Guidelines aim to provide globally applicable recommendations to help veterinary surgeons vaccinate in a standard and scientifically justified fashion.
The VGG has also updated the vaccination guidelines it offers to pet owners and breeders, as well as the series of fact sheets it has created on key global vaccine-preventable diseases of dogs and cats.
The original guidelines were published in 2007 as the WSAVA's initial response to the need for globally applicable recommendations on vaccination best practice. They were updated in 2010 and, since then, the VGG, which is supported exclusively by MSD Animal Health, has been focusing on issues relating to small companion animal infectious disease and veterinary education in Asia.
The 2015 release of the Canine and Feline Vaccination Guidelines is based on a new evidence-based classification system for vaccinology. It also includes a number of additional FAQs (110 in total). The guidelines for both vets and owners/breeders are available for free download at http://www.wsava.org/educational/vaccination-guidelines-group. Currently available in English, they are being translated into a number of languages.
Professor Michael Day, Chair of the VGG (pictured right), said: "The vaccination guidelines are one of the most frequently downloaded resources on the WSAVA's website and are gradually driving a change in vaccination practice throughout the world - a change which is set to have a major impact on day-to-day small animal practice.
"We are delighted to launch these updated versions both for veterinarians and for pet owners and breeders. We hope they will prove even more helpful and ensure that more small animals are vaccinated in a more scientifically-based, robust and safer fashion.
"We would like to thank MSD Animal Health which has been the sole sponsor of the VGG since its inception. Its support enables us to undertake our valuable work."
Medivet senior partner Adi Nell says the profession needs to consider new business models to encourage more vets into ownership, as well as fresh approaches to supporting the role.
Responding to issues and recommendations highlighted in the latest VetFutures report, such as the number of female practice owners and a perceived lack of business skills in the profession, Adi said practices need to be flexible when it comes to attracting new vets or owners.
"Client expectations have changed drastically in the past 15 years, but so have the desires of potential practice owners. The world of clinical practice is changing at a rate we’ve never seen before. Owning a practice, along with the other increasing demands on our limited time and energy, is becoming more of a challenge too. This is evident with the growth of business support and development services, indicating an increased demand for that support.
"New practice owners aren’t like previous generations. Although traditional models of ownership are changing gradually, we also need different models of working, such as flexible hours, and different methods of support are needed."
One of the trends noted in the 2014 VetFutures report was how, despite dominating the profession in terms of overall numbers, women are still less likely to be a sole principal, director or partner.
Medivet claims an excellent track record here, with a near 50/50 split of male and female branch owners/partners.
Adi added: "We’re very happy to have so many women as business partners with us. The combination of clinical freedom, business support and a real feeling of teamwork and care for each other are some of the features that enable our partnership model to work so well. The scope for clinical and business development is huge, and we do our very best to look after all our people as they grow.
"However, there are still far too many bright, talented and highly trained vets leaving the profession after too short a time. Why do we turn these diamonds into coal? We need to understand what’s driving this and how we can adapt. The VetFutures report starts to offer some of the answers – and has uncovered even more questions!"
The VetFutures report also found aspirations of practice ownership or partnership dropped from 45% among students to 25% once vets start work. Adi says that offering opportunities for vets to expand into other areas of expertise is key to reducing the decline in appetite for practice ownership. He said: "I started out offering dermatology referral services to various Medivet branches before becoming a branch partner myself. I’m now in charge of a Medivet region of 16 practices as well as being involved in strategy, marketing, HR and operations, which I absolutely love, but never predicted I would do.
"I believe fewer and fewer vets see themselves doing the same job in clinical practice for their entire careers. That includes not wanting to be an employee for life, but also not wanting to have all the responsibility and burden of individual practice ownership. A big group like Medivet allows them to find the niche they enjoy and to develop the skills they value, to the benefit of their own careers, their business success, their client care and their patients’ health."
A group of UK-based investigators from Davies Veterinary Group and the UCL School of Pharmacy has published the results of a study which suggests Keppra (levetiracetam) shows promise for the treatment of feline audiogenic reflex seizures (FARS).
The condition, which was first documented by the same investigators last April, affects older cats which typically exhibit myoclonic seizures (brief, shock-like jerks of a muscle or a group of muscles) in response to certain high-pitched sounds. Both non-pedigree and pedigree cats (in particular, Birmans) may be affected. A range of sound stimuli has been reported, including the crinkling of tin foil and a metal spoon dropping into a ceramic feeding bowl, through to firewood spitting and even texting on a phone. While avoiding the triggering sounds can reduce the incidence of seizures, this is not always practical, so this research is potentially good news for owners of affected cats.
The study, Levetiracetam in the management of feline audiogenic reflex seizures: a randomised, controlled, open label study, has been published in the Journal of Feline Medicine and Surgery1.
It compared the efficacy of two antiepileptic drugs, levetiracetam (a relatively novel medication that has proven effective in studies of people with generalised epilepsies that experience myoclonic seizures) and the much older first generation drug phenobarbital, in 57 cats diagnosed with FARS. Cats were treated with one or other drug over a 12 week period; and owners were asked to record the date, number and type of seizures, any signs of illness, side effects and changes in activity or attitude, as well as whether they thought their cat's quality of life had improved, remained the same or deteriorated since starting the medication.
All cats receiving levetiracetam showed a reduction in the number of days that they experienced myoclonic seizures by at least half. In comparison, only 3% of cats showed the same reduction when treated with phenobarbital. The majority of reported side effects, such as lethargy and inappetence, were mild to moderate in both groups and these resolved after about 2 weeks in the cats treated with levetiracetam; in the phenobarbital group, however, side effects were relatively persistent. Owners of cats treated with phenobarbital perceived no benefit from using the medication; in contrast, all of the owners of cats treated with levetiracetam commented that their cat appeared brighter and more responsive after the first couple of weeks of treatment. Moreover, five cats treated with phenobarbital were switched to levetiracetam after the study, as their owners desired improved seizure control.
Having established that levetiracetam is an effective and well-tolerated treatment for cats with hallmark myoclonic seizures, the next step is to identify whether levetiracetam will also prevent so-called generalised tonic–clonic seizures. This is another seizure type seen in cats with FARS, and is what most people think of as a 'seizure', with the cat losing consciousness and its body stiffening and jerking, often for several minutes.
Lead author on the paper, Mark Lowrie, said: "It is great to find a medication that works so well at controlling these seizures. Levetiracetam is not licensed in cats but it has proven to be a very safe drug. For affected cats to benefit, it is important that vets recognise the signs as this newly defined syndrome of FARS and that this medication is used in preference to other, less efficacious, anti-epileptic drugs."
Reference
The BVA is calling on Defra and the APHA to take an innovative approach to capturing farm animal post-mortem data, after its Voice of the Veterinary Profession survey found that 90% of production animal vets now conduct their own PMs.
In 2014, there was a 31% increase in production animal vets carrying out their own PMs following post mortem laboratory closures, yet most vets keep this PM data at their practice, with less than 5% inputting it into a national system such as NADIS, AHT or APHA and less than 1% to a benchmarking group.
Sean Wensley BVA President said: "We have heard a lot about big data and its positive uses economically and socially. Disease surveillance could be a shining example of where big data and innovative data capture comes into its own. In a global world, where diseases such as Schmallenberg and bluetongue can emerge in our livestock without having previously been seen on these shores, being able to quickly join up the dots of disparate disease data is vital.
"We understand that Defra and APHA must make difficult choices due to economic pressures and we very much welcome research already utilising post mortem data such as the Agriculture and Horticulture Development Board’s Fallen Stock Project. What we now need is clear communications and guidance on carcase collection and access to PM examination arrangements together with a determination to see this as an opportunity to innovate, exploring how digital technology can help vets in the field record and capture data that feed into national databases and help us to see the bigger picture."
BVA is asking that all vets affected by laboratory closures are clearly informed about alternative arrangements for carcase collection and PMs, with 63% of vets affected by laboratory closures reporting that carcase collection in their local area was not working well.
BVA is calling on government and industry to lead in developing new and cost efficient ways to capture and analyse disease and surveillance data, drawing on innovations in digital technology and big data analysis.
Photograph courtesy BVA
RCVS Council member and Chief Veterinary Officer Professor Nigel Gibbens has been made a Commander of the Order of the British Empire in the New Year’s Honours list for 2016.
Professor Gibbens (pictured right), who was appointed by the Privy Council to RCVS Council in 2008, has been recognised for his services to the veterinary profession and animal welfare.
Over on the other side of the world, Professor Norman Williamson, Chair of the Veterinary Schools Accreditation Advisory Committee of the Australasian Veterinary Boards Council (AVBC), has been appointed an Officer of the New Zealand Order of Merit, following an application supported by the RCVS.
Professor Williamson has been working with the College as part of the veterinary education accreditation process, taking part in university visitations both in the UK and abroad.
Bradley Viner, President of the RCVS, said: "Many congratulations to Professor Nigel Gibbens for his appointment as a CBE. As CVO, Nigel has made great strides in shaping and influencing animal health and welfare policy throughout the United Kingdom and strengthening the relationship between the Department for Environment, Food and Rural Affairs, the College and the profession at large.
"As an organisation we were also very happy to write in support of the application for Professor Williamson to become an Officer of the New Zealand Order of Merit and it is gladdening to see that his contribution to international cooperation in veterinary education has been recognised."
Photograph courtesy RCVS
Origin (previously known as Westpoint) has announced that FarmVets SouthWest has joined the group, giving further geographical coverage to its veterinary practice network.
FarmVets SouthWest has practices at Ilminster and North Petherton in Somerset and Honiton in Devon.
Eoghan McAlonan, a director of the practice, said: "We are delighted to be joining Origin. The Origin group delivers the highest standards in veterinary services to UK agriculture, and we will bring our farmer friendly services to further enhance the groups activities".
In turn Origin says it plans to bring the wide benefits of group membership, including lab services, dairy consultancy and paraprofessional services, to further enhance the high level of service the vet team at Farmvets SouthWest provide to producers in Somerset and Devon.
Jon Mouncey, Managing Director of Westpoint Farmvets, said: "Working alongside our other Origin practices in the South West region, we can now offer all livestock producers our advanced services, ensuring their stock receive the very best in veterinary care. Our group offers a unique approach to integrated veterinary services and by applying the latest technology and research we ensure that animal health and welfare is optimised, delivering real value for our clients in a challenging agricultural climate."
Defra has announced a consultation which seeks to strengthen the regulations around dog breeding and pet sales in order to improve animal welfare.
The consultation proposes to make it a requirement for anyone producing three more more litters a year to be licensed, and to clarify existing rules that require breeding businesses to be licensed.
The consultation also seeks to formalise the adoption of existing model conditions on good breeding health and welfare by making it a requirement of breeders to comply with the conditions and for local authorities to use them.
It is hoped that a consequence of any new regulations would be that local authorities can better target their enforcement activity by directing less resource at responsible businesses, for example those who are controlled by the Kennel Club’s UKAS-accredited Assured Breeders’ Scheme. This will free up resources to follow-up on reports of poor welfare at backstreet breeding establishments.
For the first time, the consultation will also clarify that online retailers selling puppies should be treated in the same way as high street pet shops by local authorities – meaning they must abide by the same licensing and welfare regulations.
Animal Welfare Minister George Eustice said: "We are aiming to reform the licensing regime we have so that smaller puppy breeding establishments must abide by the same regulations and licensing rules as bigger breeders so that the worst offenders can be dealt with more quickly.
"We are also reviewing other animal related licensed activities such as pet sales to address problems associated with the growing trend for internet sales that can contribute to impulse buying."
BVA President Sean Wesley said: "We welcome the consultation to strengthen the regulations around dog breeding and pet sales. It represents a valuable opportunity to improve licensing regulations and ensure all breeding establishments are producing only healthy, well-socialised puppies. Vets see first hand the tragic consequences that can result from irresponsible breeding, as owners are faced with serious and avoidable health and behavioural problems in their new pets. "
To take part in the consultation online, visit: https://consult.defra.gov.uk/animal-health-and-welfare/consultation-on-the-review-of-animal-licensing
Photo courtesy www.gov.co.uk Crown Copyright
The International Society of Feline Medicine (ISFM) has announced that it will be hosting monthly webinars for veterinary surgeons from January 2016.
ISFM says it has selected highly qualified speakers who are passionate about cats to cover a range of topics, including medicine, surgery, behaviour, anaesthesia and ophthalmology.
The first four webinars will be free and open to both ISFM members and non-members. Thereafter the series will be available exclusively to ISFM members at no extra cost.
To introduce the series, there will be two webinars in January. The first talk, A practical approach to the cat with respiratory distress, will be given on the 12th January by Kieran Borgeat, a European and American Specialist in Veterinary Cardiology.
The second webinar, Vaccination in cats – everything you wanted to know but were too afraid to ask, will be presented by ISFM's Veterinary Director Andy Sparkes, a European and RCVS Specialist in Feline Medicine, on 26th January.
The webinars will also be available to download later to everyone who registers.
For more information and to register for the January webinars visit: www.icatcare.org/vets/webinars.
To become an ISFM member and access future webinars, go to: www.icatcare.org/isfm-membership.
From today, porcine epidemic diarrhoea (PED) is a notifiable disease in England; veterinary surgeons and pig-keepers are now legally required to inform the Animal and Plant Health Agency of any suspicion of the disease.
If a test for PED proves positive, the Government will inform AHDB Pork, so that tracing can be carried out and improved biosecurity measures put in place.
The new measure has been introduced following co-operation between Defra APHA, AHDB Pork, the NPA and other industry bodies. Although PED is now classified as notifiable, there will be no statutory movement controls, no compulsory slaughter and no blocks on exports.
Under the new legislation in England, APHA will be legally permitted to inform AHDB Pork - which is the agreed 'appropriate organisation' - in confidence of suspect and confirmed cases. AHDB Pork will then provide biosecurity guidance to the pig unit concerned. It will also carry out tracing and alert at-risk contacts as necessary.
The aim will be to prevent spread of PED and to eliminate the disease from the pig unit. There will be no requirement to slaughter affected animals.
PED has been made lightweight notifiable following an informal consultation process with the pig industry. NPA and others called for the measure so that any outbreak can be identified as quickly as possible, spread can be prevented, and the disease can then be eliminated from the unit concerned.
AHDB Pork Chairman Meryl Ward said: "This initiative is a significant step change in partnership working between industry, Defra and the APHA to build England’s resilience to disease.
"PED is a potentially serious disease and emerging threat to our English pig industry. A unique industry led collaboration with Government led to the development of the PEDv Contingency plan to ‘identify, contain and eliminate’.
"The regulatory change to notifiable status is a critical part of the plan and will assist in early identification of affected premises, allowing more time to take effective actions to minimise the impact on the industry and therefore increasing the opportunity to eliminate the disease.
"Working together to share resource, knowledge and build vital expertise, the partnership has also developed a series of standard operating procedures, bio- security guidance as well as raising awareness across industry of the potential threat.
PED remains a significant threat to British pig-keepers. According to AHDB, outbreaks of high-impact strains caused up to 100% mortality in young pigs in the United States, knocking out around 10% of pig production in 2013-2014. The disease has since spread to Ukraine. Even with milder European Union strains, piglet mortality as high as 70% has been reported.
The Scottish Government is currently consulting on making PED similarly lightweight notifiable in Scotland.
The BVA and the Pig Veterinary Society (PVS) have welcomed the announcement. John Blackwell, Senior Vice President of the British Veterinary Association, said: "From today pig-keepers will be required to contact APHA if they have any suspicion of PED in their livestock - this is a step in the right direction and a result of joined up working between the industry, the veterinary profession and policy makers. PED is a devastating disease and we hope these measures will be sufficient to protect animals and pig-keepers in England from future outbreaks. We are encouraged by current proposals to make PED notifiable in Scotland and are keen to see similar measures in place across the rest of the UK."
Dr Mandy Nevel, President of the Pig Veterinary Society, said: "The Pig Veterinary Society was actively involved in the decision to make PED notifiable in England and we fully support the decision. Whilst we hope PED does not come into England, the legislation will facilitate rapid diagnosis, control and eradication in the event of a case occurring. We urge the rest of the UK to take similar action."
Photo: Ben Salter: Pig in a bucket
The BVA and the BSAVA have issued a statement in response to the launch of the RSA Preferred Referral Network.
"This is a business decision for RSA, in light of pressures facing the pet insurance industry - however BVA and BSAVA requested a meeting with the pet insurer earlier this year to discuss members’ concerns about RSA's policy conditions concerning cases for referral. We outlined the importance of the vet-client relationship, especially with respect to clinical decision making, and we emphasised that decisions must be made in the best interests of the pet-based on clinical indication and not be driven by cost. RSA refers to these meetings in their recent Q&A document (number 13). However, this so-called “engagement” should not be read as implying the two Associations complicity or acceptance of the changes. We stressed our concerns to RSA and would welcome opportunity for further input.
BVA and BSAVA actively encourage our members to make us aware of their concerns, and to keep us informed about how RSA’s new approach is working in practice. This will help us to continue to champion vets' voices on an issue that impacts our profession."
Ceva Animal Health has announced its biggest ever TV advertising campaign, designed to highlight the benefits of using Adaptil and Feliway, will begin on Christmas Day.
The TV advertisement for Adaptil focuses on Meg and her Cavalier King Charles Spaniel, Dude, who is anxious when Meg is away from home. With the strapline ‘Best behaviour starts here’ the advertisement will help educate pet owners on the action they should take to keep their dogs happy when they are left at home alone and Dude’s experience taking Adaptil.
Feliway’s TV advertisement features the strapline ‘Experience the difference in your home’ and focuses on the real life story of Clare and her rescue cat, Mewsli, who was often scared and anxious, so much so that she would hide under the bed and scratch the side of the chair.
The TV advertising campaign, which is aimed at ABC1 women, runs from Christmas Day until 10 January 2016 and the advertisements will air throughout the family films over the festive period with Adaptil featured during ad breaks for Paul O’Grady’s For the Love of Dogs Christmas Special on Boxing Day.
RSA has confirmed the initial 27 practices that have joined its new Preferred Referral Network, launching today.
The creation of the network means that whilst veterinary surgeons can continue to appoint referral practices as they do now, owners of animals needing a non-emergency referral outside the RSA network may need to pay £200 towards the cost of treatment.
The new rules currently apply to holders of policies issued by Tesco Bank and MORE TH>N, however RSA says it is in discussion with other insurance brands about adopting the new network.
RSA says the Preferred Referral Network will enable it to provide competitively priced products and deliver a range of benefits for customers including:
The company is highlighting the fact that its new network fields 178 RCVS, EBVS or AVMA recognised specialists, 49 Diploma holders and 71 Certificate holders or Advanced Practitioners, working at a mixture of large, multi-disciplinary centres (including five with links to university teaching hospitals), independents and corporates.
RSA says that over the last 12 months, vets have directed more than half of all RSA cases to the 27 practices in its network.
Bill Paton, Claims Director for UK and Western Europe said: “We are delighted to have twenty seven practices from around the UK join our preferred referral network. This is a huge step forward and will enable us to continue to provide competitively priced insurance cover with access to the highest standards of veterinary treatment and care.
"We expect further practices to join the Network in due course and we are actively engaged in discussions with a number of referral practices of varying size and scale, which have expressed an interest in joining."
The 27 referral practices are:
South East
South West
Midlands
North West
North East
East
Scotland
* referral arrangements still being finalised
Pets’n’Vets has announced that it is burying a veterinary time capsule under its new Roundhouse Veterinary Hospital being built on the southside of Glasgow.
Brainchild of Pets’n’Vets partner Ross Allan, the idea is that the capsule will reveal to future generations how the cutting edge veterinary facility in Glasgow looked in 2015 and help show just how far veterinary science has developed when it is opened in 2115.
Ross said: "The aim of the time capsule is to document the memories, hopes and dreams of our staff at this exciting point in our story, and preserve them as best we can for discovery in 100 years."
The capsule, which was curated with help from The Veterinary History Society and the British Library, contains:
Ross said: "As an orthopaedic surgeon, I’m used to dealing with cutting edge metal plates, screws and pins when fixing fractured legs, but helping develop this capsule was an entirely new challenge for me. It is very rewarding to use great science to preserve these memories as best we can.
"The time capsule has been designed with this in mind: maintaining optimal humidity, zero oxygen and steady temperature. It will be welded shut before being flushed with argon gas, all measures to help preserve the photos, letters and other contents for those that are lucky enough to open it."
In order preserve the contents as best as possible, Ross sought the advice of Glasgow Museums, which advised including archive quality paper and ink to prevent fading of writing and images, as well as the use of corrosion bags to contain the metallic surgical implants.
"I thought it would be fun to include the implants we currently use for cruciate surgery," said Ross. "This is one aspect of veterinary surgery that has especially progressed over the last 30 years and will doubtlessly continue to progress in the years ahead."
David Thomson, Preventative Conservation Officer, Glasgow Museums, added: "Sending things safely into the future is very like preserving the collections we have in the Museum. The Veterinary Time Capsule meets the highest standards for slowing down the normal ageing effects of our environment and we wish it well on its journey through time."
The time capsule has been registered with the International Time Capsule Society (ITCS) at Oglethorpe University, Atlanta, USA.
Ross said: "This will ensure the capsule is followed up and not, like the majority, lost forever," said Ross. "When opened, the contents should offer a snapshot into Scottish 21st Century veterinary medicine and perhaps it can offer a small legacy to the future of veterinary medicine too.
"Veterinary medicine is going through a huge transition at present – the scope of what is available today is poles apart from what was possible even 10 years ago – and we are delighted to help document its development in Glasgow to this point. Just what might be possible when the capsule is opened in 2115 is mind boggling!"
The BVA and the RCVS are inviting applications from veterinary surgeons to join the new Vet Futures Action Group, set up to drive forward the ambitions identified in the Vet Futures report launched at BVA Congress at the London Vet Show on 20 November.
The Vet Futures report, Taking charge of our future: A vision for the veterinary profession for 2030, was the culmination of a year-long joint project by BVA and RCVS designed to help the veterinary profession prepare for, and shape, its own future. The Action Group is a vital next step in the Vet Futures project, ensuring the delivery of the report’s six ambitions and 34 recommendations.
BVA and RCVS are seeking seven veterinary surgeons and one veterinary nurse to join the Action Group to ensure there is buy-in from across the professions and to drive forward workstreams of activity. The group will be co-chaired by the BVA and RCVS Presidents, and both Junior Vice-Presidents will sit on the group. Action Group members will be independent and will not represent, or be required to report back to, any particular organisation.
Veterinary surgeons or nurses keen to apply for an Action Group role should have experience of working as an active member of a group or committee and the ability to deliver, engage and inspire others. The veterinary surgeon members should have specific expertise, knowledge and experience in relation to at least one of the Vet Futures ambitions or the cross-cutting issue of veterinary education. The ambitions cover:
Successful applicants must be able to attend three all-day meetings in London (9 February, 17 March and 12 May) and an all-day Vet Futures Summit (20 June), with a time commitment totalling approximately seven days between February and June 2016. The group will be supported by BVA and RCVS staff. For the full Vet Futures Action Group role profile and terms of reference, please visit: www.vetfutures.org.uk.
The deadline for applications is 12 noon, 31 December 2015.
Animalcare has launched Vetaclean, a new range of disinfectants which the company says has a notably high kill activity against canine parvovirus and common feline viruses such as FIV, FeLV and FCV.
The range comprises Vetaclean Parvo Advance, a surface disinfectant-cleaner, Vetaclean enzymatic instrument detergent-cleaner, and an instrument disinfectant.
Animalcare Product Manager, Tony Liepman, said: "Veterinary nurses tell us that canine parvovirus is the most challenging and resistant pathogen they work with, and so we set this as our benchmark for the Vetaclean disinfectant products. Tested under EN protocols and having 99.99% + kill activity against parvovirus, our new disinfectants demonstrate high efficacy against a broad range of bacteria, including MRSA/MRSP, fungi, viruses, mycobacteria and spores.
"Infection control is in the spotlight at the moment, highlighted by initiatives from within and outside our industry. Firstly, the new Practice Standards Scheme - launched at the same time as our range - places great emphasis on having a rigorous biosecurity policy. This includes requirements for personal hygiene as well as cleanliness of premises and equipment. High-level decontamination of instruments and equipment is ensured through the Vetaclean two-stage process, which works with even soiled instruments or equipment, and in under 20 minutes. The products have also been designed to be suitable for use on the most specialised equipment seen in today’s practices, including flexible or rigid endoscopes, ultrasonic baths, aspirators, arthroscopes and re-processing machines.
"Importantly, the active ingredients in the Vetaclean range meet the criteria of the new EU Biocides Regulations, policed by the Health and Safety Executive in the UK, which came into effect on 1st September 2015. All products with biocidal activity now need to undergo a complex registration process, ensuring the products are not harmful to people, the environment or animals. The rigorous process may see many disinfectant manufacturers pull out of the market, resulting in less choice. Further, the Vetaclean range does not contain Poly (hexamethylene biguanide) hydrochloride (PHMB). The European Chemicals Agency (ECHA) is currently proposing that PHMB is listed as a category 2 carcinogen."
The Vetaclean Parvo Advance range includes a 1 litre lavender product in a self-dosing bottle, 5 litre apple and lemon-fragranced liquid concentrates and unfragranced large surface wipes. There are two different dilution rates: a general purpose dilution rate for most pathogens at 1:100 (10ml per litre), and a parvocidal dilution rate at 1:50 (20ml per litre). Animalcare says the alkaline-based formula ensures that the products are compatible with a wide range of materials and are non-staining. Both the enzymatic instrument cleaner and instrument disinfectant are available in 2 litre concentrates (incorporating a calibrated dosing reservoir).
The Vetaclean range is available now in wholesalers. The company has also produced a brochure Hygiene in practice, a guide to veterinary infection control from Animalcare, designed to help familiarise veterinary professionals with the principles and uses of the product range. There is also a special launch offer of Buy-4-Get-One-Free available from Animalcare representatives.
For further information, contact Animalcare on 01904 487687, or speak to your regional Animalcare representative: www.animalcare.co.uk/contact-us.
Zoetis has announced the launch of Ketavet.
The intravenous anaesthetic solution containing ketamine is available in 10ml and 50ml presentations. The new product coincides with the re-classification of ketamine as a schedule 2 drug.
Ketavet is a clear, colourless solution for injection containing ketamine 100 mg/ml (equivalent to 115.36 mg/ml ketamine hydrochloride) with benzethonium chloride 0.1 mg/ml as a preservative. It can be used to induce anaesthesia in horses in conjunction with xylazine, detomidine or romifidine.
Ketavet, along with other ketamine containing products, has been moved to Schedule 2 of the Misuse of Drugs Regulations, which took effect from 30 November 2015. This enables tighter controls on the record keeping, prescribing and safe custody of products containing this active. More information on the specific requirements which will need to be met following the schedule change can be found on the VMD website https://www.gov.uk/government/news/amendments-to-the-misuse-of-drugs-regulations-2001
Penny McCann, Equine Product Manager at Zoetis said: "Ketavet is an important product in our anaesthesia portfolio. We are keen to help veterinary surgeons keep up-to-date with the reclassification of ketamine and with this in mind our new product packaging clearly reflects ketamine’s revised status as a schedule 2 drug."
For more information, contact your Zoetis Account Manager.
The Evidence-Based Veterinary Medicine Learning Consortium has announced the launch of a new online tutorial (www.ebvmlearning.org) designed to make evidence-based veterinary medicine (EBVM) accessible to the veterinary profession worldwide.
The online tutorial, funded by the RCVS Knowledge Target Grants initiative and led by Dr Kristen Reyher at the University of Bristol along with Drs Rachel Dean and Marnie Brennan from the Centre for Evidence-based Veterinary Medicine at the University of Nottingham, begins with an introductory module and then focuses on the five key areas of EBVM:
The learning resource, which can be used on various platforms and devices, is suitable for students and practitioners for self-study, and can be used as a stand-alone tutorial or as individual teaching modules to support other EBVM teaching or continuing professional development.
The online tutorial uses best educational practice and includes formative multiple choice questions, short tasks and recommendations for further study. It is intended to be a source of knowledge, bringing together the essentials of EBVM into one place, and highlights many other links to resources and organisations that are available to further learners’ knowledge about the subject.
Dr Kristen Reyher, Senior Lecturer in Farm Animal Science in the School of Veterinary Sciences, who led the project team, said: "It is hoped that the development of this resource will increase awareness of EBVM in the veterinary profession, and allow practitioners the opportunity to develop the skills needed to utilise EBVM in everyday clinical practice."
Future aims of the project team include designing methods of cataloguing and disseminating evidence synthesis to support clinical decision-making and evidence-based veterinary practice, improving and standardising the teaching of EBVM to undergraduate and postgraduate students at veterinary schools internationally, and building a community of practice in this area.
Zoetis has announced that it has upscaled production of Apoquel, the oral therapy for the treatment of canine pruritus, and it is now available to all UK vet practices on unlimited distribution.
The company says that there was unprecedented demand for Apoquel following its launch last year, so it had to introduce an allocation system to ensure that those dogs that had started on the product were able to remain on it for as long as their vet deemed appropriate.
During this time, Zoetis focused on strengthening its manufacturing capacity to make the product more widely available.
Apoquel is the first Janus Kinase (JAK) inhibitor approved for veterinary use. Zoetis says it provides rapid and sustained relief of pruritus and improves skin lesions. Its novel mechanism of action on the JAK enzyme is specifically designed to target the pruritogenic and pro-inflammatory pathways involved in the itch cycle. This, says the company, allows effective reduction of allergic itch regardless of its cause as well as improvement of skin lesions associated with allergic skin diseases and atopic dermatitis.
Ned Flaxman, companion animal business unit director at Zoetis said: “We are very grateful to all our veterinary customers for bearing with us through this product shortage. Over the past 18 months we have incorporated a variety of safeguards to ensure that Apoquel supply will better align with demand. We have reduced the length of time it takes to manufacture Apoquel and added further production capacity.
“It’s been a very long 18 months for everyone involved but we’re looking forward to a very good Christmas and New Year with Apoquel fully back in stock and we’d like to thank all of our customers for their patience.”
For more information, visit www.zoetis.co.uk/apoquel.
Barrettine Environmental Health has launched MiteMax, a new treatment for poultry red mite (PRM) with a physical mode of action.
Charles Phillips from Barratine said: "PRM poses a significant threat to laying hens particularly, with infestation costing the UK egg industry in excess of an estimated €3 million per annum through PRM control and lost production. In the UK, PRM is prevalent in varying percentages according to the rearing system used. Caged birds are estimated to have a variable 7.5 to 87.5 % prevalence. Free range systems are estimated to have 60 % prevalence of PRM, with organic systems higher at 78 %. Less intensive systems have a greater prevalence of PRM due to the higher number of cracks and crevices associated with a more enriched environment1."
MiteMax is applied directly to a shed’s inner surfaces via knapsack sprayer, rendering the surfaces sticky and permanently immobilising red mites that come into contact with them.
According to the company, the new product - which is designed to fit into and encourage integrated pest management practices - provides rapid knock-down of poultry red mite.
Charles added: "The physical mode of action of MiteMax makes it effective against pesticide-resistant mites. MiteMax is specifically formulated to penetrate surface dust making it highly effective at reaching mites harbouring deep in crevices."
In conjunction with robust cleansing practices, Ian Whelan an expert in physical insect control techniques says MiteMax fits neatly into an integrated pest management style of husbandry: "Using treatments with different modes of action together as part of a flock health plan ensures each one fulfils its potential."
MiteMax is available nationwide from Barrettine Environmental Health's appointed distributors.
Boehringer Ingelheim has launched Bitesize (www.bi-bitesize.co.uk), an educational website about canine epilepsy for veterinary surgeons.
Boehringer’s Brand Manager Craig Roxburgh said: "We have teamed up with eight neurology experts working in referral centres across the UK. These experts have covered the questions most commonly encountered when managing epilepsy cases in first opinion practice, which we hope will assist vets in their epilepsy case management."
Answers to questions are delivered as short video clips of between one and three minutes, optimised for use on smartphones and tablet devices to make them available in the practice or on the move.
Craig added: "Canine epilepsy can be a complex condition to manage. We hope therefore that when cases present, Bitesize will prove a useful and handy ‘go-to’ resource for vets to access information at the time they need it."
There's a chance to win an iPad if you visit the new site before 29th February 2016.
Merial has published Give Them Just What they Need, a guide to the key considerations concerning the vaccination of cats.
The company says it produced the guide after conducting research in which 76% of small animal veterinary surgeons said they are not fully aware of the most recent feline vaccination guidelines, and 98% said they'd find a guide useful.
The survey1, which was conducted amongst 114 UK small animal vets, also showed that whilst 82% of vets are aware of the existence of feline vaccination guidelines from organisations such as the World Small Animal Veterinary Association (WSAVA) and European Advisory Board on Cat Diseases (ABCD), 58% don’t know the content well, and a further 18% were not aware of the guidelines at all.
In a concurrent survey of 1000 cat owners2, 60% said they would have more confidence in their vet knowing that they were vaccinating according to the latest guidelines. The cat owner survey also found that 80% rely on their vet for information about vaccination, and 60% would like more information about vaccination.
Claire Edmunds, product manager at Merial, said: "Understanding that vets are busy people and using all of the insight that we have gathered from vets and owners to shape the content of the guide, we have condensed previously published vaccination recommendations from organisations such as WSAVA and ABCD into really useful, practical advice. The new guide and complementary support materials will hopefully prove to be really valuable resources for vets, giving them the information they need when reviewing their vaccination protocols, in a quick, easy-access format.
"By being better informed about the latest recommendations, we want vets to feel more confident in discussing all aspects of vaccination with their clients. With the majority of cat owners saying that they rely on their vet for vaccination information and nearly half stating that their vet clearly explaining the benefits of vaccination would increase their compliance in vaccinating their cat, this obviously will be beneficial to both the practice and pet cats."
Merial has also produced supporting materials for use alongside the guide, including a take-home leaflet for owners and digital assets for social media and newsletter use, designed to help vets start discussions about vaccination.
Give Them Just What they Need is available from your regional Merial Territory Manager or for download at https://goo.gl/7Uas3y
References
Dorset-based homeopathic practitioner Philippa Rodale, who requested that her name be removed from the RCVS Register in July, has been convicted of cruelty at Weymouth Magistrates Court.
The case related to Mrs Rodale's treatment of a female foxhound called 'Dangerous', which had been brought to her after being hit by a car.
The dog was reported to the RSPCA by a member of the public who was alarmed after seeing the dog lying in the surgery, whining and dragging her back legs. The court heard that at this point, Dangerous had already been in the care of the clinic for 10 days, during which time Mrs Rodale had administered both homeopathic and conventional treatment, but had failed either to x-ray the animal or give adequate pain relief. In addition, the court heard hygiene and nursing care standards were poor.
RSPCA inspector Marie Griffiths said: "When I found Dangerous she was just lying on a tiled floor with no bedding and only a towel propping up her head, paralysed, and covered in infected pressure sores. She couldn’t even stand up.
"It was a shocking sight and definitely not something that I would ever expect to see anywhere, let alone in a veterinary practice.
"She was clearly in agony and had just not received the level of care and attention that you would expect from a vet. She was suffering so much that sadly a decision had to be made by another veterinary surgeon to do the kind thing and finally put her to sleep.
"The RSPCA exists to protect animals from cruelty and suffering and to defend them when their needs are not being met and we hope that this case goes some way to showing that no-one is exempt from providing animals with the duty of care that they deserve - not only morally, but because it is also the law.”
Mrs Rodale was ordered to pay £4,000 in costs to the RSPCA as well as £520 in court charges and a £15 victim surcharge.
Do you think the RCVS should issue a public statement about homeopathy, and require that veterinary surgeons inform owners about the scientific evidence which demonstrates it is ineffective? If so, visit The Campaign For Rational Veterinary Medicine, and sign the petition.
Picture BNPS
The RCVS has brought out a new publication to help members of the veterinary and veterinary nursing professions understand their legal and professional obligations regarding controlled drugs.
Controlled Drugs Guidance is a consolidation of existing advice and guidance on controlled drugs from a number of organisations including the RCVS itself, the Veterinary Medicines Directorate (VMD), the British Small Animal Veterinary Association (BSAVA) and the Home Office. The guide also gives details of the existing legislation concerning controlled drugs, namely the Misuse of Drugs Act and associated regulations.
The guidance provides advice on a variety of topics to reflect the common queries the RCVS Advice Team receives, such as storage, destruction and disposal; keys and keyholders for controlled drugs cabinets; controlled drugs in vehicles; and veterinary nurses administering controlled drugs.
The publication also deals with specific controlled drugs such as ketamine which, on 30 November 2015, was rescheduled to a Schedule 2 controlled drug, meaning that it is now subject to the same strict storage, prescription, dispending, destruction and record-keeping requirements as other medicines in this Schedule.
Laura McClintock, Standards and Advisory Manager at the RCVS, said: “We hope that this publication will help members of the profession navigate the often complex legislative and professional requirements regarding controlled drugs, as well as imparting best practice advice on how they should be stored and disposed and so on.
"This publication has also been endorsed by our colleagues in the Home Office, VMD and BSAVA and, because this is an area that is subject to regular change, we will make sure to keep it up-to-date as and when the regulations change."
The publication is available to download from the RCVS website at www.rcvs.org.uk/publications
IDT Biologika and Hysolv Animal Health have announced the publication of A guide to oedema disease in pigs, a six-page booklet written to help pig producers understand the causes, effects and treatment of this ailment.
Author, F Javier Salquero, an independent European veterinary specialist in porcine health management, outlines the risk factors, how to identify oedema disease, current methods of treatment and prevention strategies. The booklet includes a table of the symptoms to be expected in new-born, suckling, post-weaned, grower-finishers and adult pigs.
The booklet concludes that treatment of oedema disease is generally unsuccessful and most pigs showing clinical signs die. However, preventive measures include adjustment of feeding regimes, stress reduction, improved biosecurity and vaccination.
Hysolv director, Richard Brealey said: "Oedema is a widespread, lethal and economically-important disease in pigs, and there is increasing pressure in Europe to reduce the use of antibiotics in livestock. Fully understanding this disease is a first step to control and prevention".
Hysolv says a German calculation showed a reduction in margin of 83 Euros (£74) per sow, equivalent to 41,000 Euros (£32,500) for a 500-sow herd, due to oedema.
The booklet — printed on heavy duty glossy card – suitable for use in piggeries — is available, free, by visiting the Hysolv website: www.hysolv.co.uk
Invicta Animal Health has announced the launch of Ocuvance, a nutritional supplement to support ocular health in dogs and cats.
The company says Ocuvance is formulated to provide an antioxidant complex supporting and maintaining the health of eyes. The tablets contain lutein, a xanthophyll pigment found within the eye. They also contain anthocyanosides derived from bilberry extract to support rhodopsin production. The formulation also contains vitamins C and E, zinc and selenium.
Ocuvance is presented in packs of 30 scored tablets; sufficient for a one month supply for the average sized dog.
Rob Watkins, Managing Director of Invicta, said: "We are delighted to make Ocuvance available to veterinary surgeons in the UK. A recent veterinary study1 has shown there can be significant ophthalmic benefits of antioxidant supplementation.
We carefully formulated Ocuvance to provide a range of high quality ingredients to maintain normal visual function whilst still being affordable for owners”.
Ocuvance is now available from all veterinary wholesalers.